Hirsutism, virilism, polycystic ovarian disease, and the steroid-gonadotropin-feedback system: a career retrospective.
This career retrospective describes how the initial work on the mechanism of hormone action provided the tools for the study of hirsutism, virilism, and polycystic ovarian disease. After excessive ovarian and or adrenal androgen secretion in polycystic ovarian disease had been established, the question whether the disease was genetic or acquired, methods to manage hirsutism and methods for the induction of ovulation were addressed. Recognizing that steroid gonadotropin feedback was an important regulatory factor, initial studies were done on the secretion of LH and FSH in the ovulatory cycle. This was followed by the study of basic mechanisms of steroid-gonadotropin feedback system, using castration and steroid replacement and the events surrounding the natural onset of puberty. Studies in ovariectomized rats showed that progesterone was a pivotal enhancer of estrogen-induced gonadotropin release, thus accounting for the preovulatory gonadotropin surge. The effects of progesterone were manifested by depletion of the occupied estrogen receptors of the anterior pituitary, release of hypothalamic LHRH, and inhibition of enzymes that degrade LHRH. Progesterone also promoted the synthesis of FSH in the pituitary. The 3α,5α-reduced metabolite of progesterone brought about selective LH release and acted using the GABA(A) receptor system. The 5α-reduced metabolite of progesterone brought about selective FSH release; the ability of progesterone to bring about FSH release was dependent on its 5α-reduction. The GnRH neuron does not have steroid receptors; the steroid effect was shown to be mediated through the excitatory amino acid glutamate, which in turn stimulated nitric oxide. These observations led to the replacement of the long-accepted belief that ovarian steroids acted directly on the GnRH neuron by the novel concept that the steroid feedback effect was exerted at the glutamatergic neuron, which in turn regulated the GnRH neuron. The neuroprotective effects of estrogens on brain neurons are of considerable interest.
Dept. of Physiology and Endocrinology, Georgia Health Sciences University, 1120 15th St., Augusta, GA 30912, USA. vmahesh@georgiahealth.edu
Virendra B
VB
Mahesh
D000728:Androgens / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D000818:Animals; D001253:Astrocytes / Q000187:drug effects / Q000378:metabolism; D004967:Estrogens / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D018846:Excitatory Amino Acids / Q000378:metabolism; D025461:Feedback, Physiological / Q000187:drug effects; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D006062:Gonadotropins / Q000378:metabolism*; D006628:Hirsutism / Q000378:metabolism* / Q000628:therapy; D020249:Hormone Replacement Therapy; D006728:Hormones / Q000378:metabolism*; D006801:Humans; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism; D007986:Luteinizing Hormone / Q000378:metabolism; D010062:Ovulation Induction; D011085:Polycystic Ovary Syndrome / Q000378:metabolism* / Q000628:therapy; D011374:Progesterone / Q000737:chemistry / Q000378:metabolism / Q000627:therapeutic use; D014770:Virilism / Q000378:metabolism* / Q000628:therapy
D000728:Androgens; D004967:Estrogens; D018846:Excitatory Amino Acids; D006062:Gonadotropins; D006728:Hormones; D011374:Progesterone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone